Awiqli Once Weekly Basal Insulin

Awiqli Once Weekly Basal Insulin in India: Novo Nordisk Launches Revolutionary Diabetes Treatment

Awiqli once weekly basal insulin in India marks a major breakthrough in diabetes care. Learn about Novo Nordisk’s insulin icodec, its benefits, key facts, historical background, FAQs, and exam-oriented points for UPSC, SSC, Banking, Railways, Defence, and State PSC exams. A Major Milestone in India’s Diabetes Care Global pharmaceutical company Novo Nordisk has launched Awiqli…

Read Full News
Childhood Obesity Prevention Initiative

Childhood Obesity Prevention Initiative India: WHO Foundation and Novo Nordisk Collaboration

Childhood obesity prevention initiative India launched by WHO Foundation and Novo Nordisk focuses on school health programs, early intervention, and awareness to reduce lifestyle diseases. WHO Foundation and Novo Nordisk Launch Initiative to Tackle Childhood Obesity in India Introduction: A Major Step Towards Combating Childhood Obesity The WHO Foundation in collaboration with Novo Nordisk has…

Read Full News